CONTI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 2.726
AS - Asia 2.080
EU - Europa 1.771
SA - Sud America 280
AF - Africa 98
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 6.961
Nazione #
US - Stati Uniti d'America 2.630
SG - Singapore 970
CN - Cina 596
IE - Irlanda 344
DE - Germania 301
FI - Finlandia 296
SE - Svezia 268
BR - Brasile 213
UA - Ucraina 188
HK - Hong Kong 170
TR - Turchia 128
VN - Vietnam 100
NL - Olanda 82
IT - Italia 78
ZA - Sudafrica 74
CA - Canada 71
GB - Regno Unito 64
AT - Austria 38
RU - Federazione Russa 37
AR - Argentina 27
BE - Belgio 20
IN - India 18
JP - Giappone 18
FR - Francia 16
MX - Messico 15
PL - Polonia 14
BD - Bangladesh 13
EC - Ecuador 13
IQ - Iraq 13
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
VE - Venezuela 7
CL - Cile 6
RO - Romania 6
EG - Egitto 5
LT - Lituania 5
PY - Paraguay 5
ES - Italia 4
EU - Europa 4
KR - Corea 4
NP - Nepal 4
TN - Tunisia 4
AO - Angola 3
AZ - Azerbaigian 3
ID - Indonesia 3
KE - Kenya 3
MA - Marocco 3
PK - Pakistan 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
GE - Georgia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GD - Grenada 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
QA - Qatar 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TM - Turkmenistan 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
YE - Yemen 1
Totale 6.961
Città #
Singapore 496
Chandler 415
Dublin 344
Jacksonville 302
Ashburn 245
Santa Clara 239
Hong Kong 170
Dearborn 158
Beijing 155
Izmir 119
Munich 98
Boardman 96
Dallas 88
Nanjing 80
Ann Arbor 78
Johannesburg 73
San Mateo 72
Princeton 70
Helsinki 66
Toronto 49
Shanghai 48
Wilmington 48
Los Angeles 38
Vienna 38
Bremen 36
Ho Chi Minh City 33
Columbus 29
New York 29
Moscow 28
Nanchang 26
Parma 26
Hanoi 25
Hebei 25
São Paulo 22
Brussels 20
Jiaxing 20
Des Moines 19
Jinan 19
Shenyang 19
Tokyo 18
Kunming 15
Tianjin 14
Turku 14
Denver 13
Hefei 13
Seattle 13
Warsaw 13
Buffalo 12
Montreal 12
London 11
The Dalles 10
Woodbridge 10
Changsha 9
Houston 9
Council Bluffs 8
Norwalk 8
Trezzano Sul Naviglio 8
Brasília 7
Brooklyn 7
Coventry 7
Frankfurt am Main 7
Atlanta 6
Baghdad 6
Chennai 6
Mestre 6
Salvador 6
Chicago 5
Grafing 5
Guayaquil 5
Haiphong 5
Orem 5
Ottawa 5
Phoenix 5
Quito 5
Stockholm 5
Taiyuan 5
Tappahannock 5
Tashkent 5
Auburn Hills 4
Belo Horizonte 4
Biên Hòa 4
Bogotá 4
Düsseldorf 4
Falls Church 4
Londrina 4
Nova Iguaçu 4
Poplar 4
Rio de Janeiro 4
San Francisco 4
Taizhou 4
Xian 4
Asunción 3
Baku 3
Boston 3
Buenos Aires 3
Bắc Ninh 3
Can Tho 3
Chengdu 3
Feira de Santana 3
Guangzhou 3
Totale 4.368
Nome #
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 228
Inhibition of human and avian type A Influenza virus multiplication by NEK-2 treatment 179
Antibodies as a source of anti-infective peptides: an update 163
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 147
Abortive replication of influenza A viruses in HeLa 229 cells 147
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment. 135
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 131
Peptides from the inside of the antibodies are active against infectious agents and tumours 131
Detection of IgA and IgM antibodies to HIV-1 in neonates by radioimmune western blotting. 128
Defective insertion of haemagglutinin as a cause of abortivity of influenza A viruses in HeLa 229 cells. 123
Inhibition by prostaglandin PGA1 on the multiplication of influenza virus is a dose-dependent effect 115
Inhibition of multiplication of RNA genome-containing viruses performed by differentconcentrations ofMESNA 113
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali 113
Effect of coumermycin on influenza A virus replicative cycle. 111
Biological characterization of FPV, Ulster 73, replicative cycle. 109
Improved immunoblotting for the detection and quantitative analysis of antibodies to human immunodeficiency virus. 108
Chromomycin A3 inhibits influenza a virus multiplication in chick embryo fibroblast cells 108
Different patterns of replication in influenza virus-infected KB cells 107
Determinazione di anticorpi anti-HIVmediante un sistema modificato di immunoblotting 107
Attività terapeutica di un peptide sintetico killer nei confronti di virus influenzali aviari ed umani. 105
Aspetti epidemiologici delle batteriemie in Italia: osservazioni effettuate presso il Laboratorio di Microbiologia di Parma 105
Control of influenza virus polypeptide synthesis 102
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 101
Cerulenin inhibits production of mature virion particles in chick embryo fibroblasts infected by influenza A viruses. 101
Different patterns of replication in influenza virus-infected KB cells 101
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 100
The use of radioimmune western blotting to evaluate indeterminate western blotting results in blood donor HIV serodiagnosis 100
Batteriemie da germi anaerobi 100
Inhibition of late influenza virus genome expression by diamidinophenylindole. 100
Inhibition of multiplication of RNA genome containing viruses performed by different concentrations of MESNA. 99
Physical characterization of N4-coded messenger RNA 99
Inhibition of human and avian type A Influenza virus multiplication performed by MESNA 99
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT Description not available for EP1596851 (A1) Description of corresponding document: WO2004069235 (A1) 99
Inibizione della replicazione di virus influenzali mediante trattamento di cellule infette con un peptide sintetico killer 97
Great reduction of human and avian type A Influenza virus multiplication by MESNA ( sodium-2 mercaptoethanesulfonate ) treatment 97
Restriction of Influenza virus multiplication induced by PK peptide treatment 97
USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 97
Restriction of A/WSN/33 influenza virus multiplication by prostaglandin PGJ2 97
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 96
CERULENIN INHIBITS THE PRODUCTION OF MATURE VIRION PARTICLES IN CHICK EMBRYO FIBROBLASTS INFECTED BY INFLUENZA A VIRUSES 95
Inibizione della migrazione della emoagglutinina HA del virus Ulster 73 indotta dalla prostaglandina PGA1 93
Inhibition of production of Influenza A viral particles induced by PGA1 treatment 91
Spettro d'azione universale di mimotopi killer antifungini 90
ABORTIVE REPLICATION OF INFLUENZA A VIRUSES IN HELA 229 CELLS 90
RIWB in comparison with conventional WB, second and third generation ELISA assays for the serodiagnosis of HIV infection 88
ROLE OF ACYLATION OF VIRAL HAEMAGGLUTININ DURING THE INFLUNZA VIRUS INFECTIOUS CYCLE 88
Phosphorylation of viral polypeptides in cells infected with influenza virus 86
Effetto di PGA1 e PGJ2 sulla replicazione del virus influenzale 86
Indagine epidemiologica dei microrganismi responsabili di infezioni nosocomiali caratterizzate da batteriemie e/o fungiemie 85
Inibizione della migrazione della emoagglutininaHA del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGJ2 84
Radioimmune western blotting in comparison with conventional western blotting, second and third generation ELISA assays for the serodiagnosis of HIV-1 infection. 84
Migration of influenza virus-specific polypeptides from cytoplasm to nucleus of infected cells. 84
GREAT REDUCTION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION BYMELITTIN TREATMENT 84
Macromolecular synthesis during abortive infection of KB cells by influenza virus 82
Sepsi da catetere venoso centrale in corso di insufficienza renale. Aspetti epidemiologici e clinici. 82
Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells 81
Role of acylation of viral haemagglutinin during the influenza virus infectious cycle 80
Inhibitory effect of diamidinophenylindole on the replication of influena virus in permissive cellular host. 78
INHIBITION OF HUMAN AND AVIAN TYPE A INFLUENZA VIRUS MULTIPLICATION PERFORMED BY MESNA. 78
Viral protein synthesis during replication of bacteriophage T1. 77
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT 77
Restriction of Influenza virus multiplication induced by treatment with a yeast killer toxin-like synthetic peptide 76
Inibizione della moltiplicazione del virus influenzale umano WSN/33,H1N1,indotta dalla prostaglandina PGA1:effetto dose-dipendente 76
Therapeutic Activity of an Anti Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 71
THE USE OF SODIUM 2-MERCAPTOETHANESULFONATE AS ANTIVIRAL AGENT. 71
INHIBITION OF LATE INFLUENZA VIRUS GENOME EXPRESSION BY DIAMIDINEPHENILINDOLE 66
Synthesis of stable RNA in "Escherichia coli" cells infected with N4. 66
Inhibition of multiplication of RNA genome- containing viruses performed by different concentrations of MESNA. 65
Radio immune Western blotting: a possible solution to indeterminate conventional Western blotting results for the serodiagnosis of HIV infections. 65
Il significato delle colture intraoperatorie della parete e del trombo negli interventi per aneurisma dell'aorta addominale 60
Totale 6.974
Categoria #
all - tutte 23.704
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.704


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 6 33 5 102 7 77 10
2021/2022339 4 3 2 17 18 11 48 56 20 36 24 100
2022/20231.389 130 129 77 131 136 180 4 95 458 7 26 16
2023/2024339 22 37 5 8 34 76 31 26 12 8 33 47
2024/20251.570 17 83 89 71 160 255 60 65 219 112 127 312
2025/20261.542 249 228 321 235 438 71 0 0 0 0 0 0
Totale 6.974